Clinical studySevere allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency☆
References (52)
- et al.
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase
Biochem Pharmacol
(1966) Inhibition of urate production by allopurinol
Biochem Pharmacol
(1977)- et al.
A competitive protein binding assay for allopurinol and oxipurinol
Anal Biochem
(1980) - et al.
Acute cholangitis after allopurinol treatment
Lancet
(1978) - et al.
Vasculitis with allopurinol therapy
Am Heart J
(1970) - et al.
Granulomatous hepatitis in a patient receiving allopurinol
Gastroenterology
(1972) - et al.
Allopurinol associated arteritis (letter)
Lancet
(1976) - et al.
Allopurinol hypersensitivity: granular deposition of IgM at the dermal-epidermal junction
Am J Med
(1976) - et al.
Oral presentation of toxic epidermal necrolysis
J Oral Maxillofac Surg
(1982) - et al.
The allopurinol hypersensitivity syndrome
J Am Acad Dermatol
(1979)
Inhibition of human purine nucleoside phosphorylase
J Biol Chem
(1968)
Allopurinol-induced suppressor T cell dysfunction: a hypothesis
J Am Acad Dermatol
(1981)
Renal clearance of oxipurinol, the chief metabolite of allopurinol
Am J Med
(1968)
Allopurinol
Asymptomatic hyperuricemia: the case for conservative management
Ann Intern Med
(1978)
Allopurinol kinetics
Clin Pharmacol Ther
(1978)
Severe allopurinol hypersensitivity: association with thiazides and prior renal compromise
Arch Intern Med
(1974)
Prediction of creatinine clearance from serum creatinine
Nephron
(1976)
Allopurinol hypersensitivity syndrome: effects and treatment
Va Med
(1978)
Allopurinol hypersensitivity vasculitis and liver damage
West J Med
(1977)
Allopurinol hepatotoxicity
Arthritis Rheum
(1977)
Allopurinol induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction
Arch Intern Med
(1978)
Massive hepatic necrosis in a patient receiving allopurinol
JAMA
(1977)
Liver granulomas and allopurinol
Br Med J
(1978)
Allopurinol associated hypersensitivity reactions: cutaneous and renal manifestations
Aust NZ J Med
(1977)
Ocular manifestations of toxic epidermal necrolysis associated with allopurinol use
Arch Opthalmol
(1977)
Cited by (638)
Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase
2023, Journal of Biological ChemistryRecent advances on the biological activities of purple sweet potato anthocyanins
2023, Food BioscienceHepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins
2023, MacSween's Pathology of the Liver, Eighth EditionInitiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study
2022, American Journal of Kidney Diseases
- ☆
This study was supported in part by grants from the Veterans Administration and Grant RO1-CA-26418 from the U.S. Public Health Service.
- 1
From the Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, and Veterans Administration Medical Center, Nashville, Tennessee.
Copyright © 1984 Published by Excerpta Medica Inc.